Drug-Resistant TB Self-Reporting of Drug-Related Adverse Events During Treatment
Author(s): Challenge TB, KNCV Tuberculosis Foundation
Year: 2019
Resource Tag: Drug-resistant TB
Guide for QTc monitoring and management of drug-resistant TB patients with QT-prolonging agents
Author(s): Challenge TB, KNCV Tuberculosis Foundation
Year: 2018
Filed under: DR-TB, Drug-resistant TB, Guidance and Tools, Management, Monitoring, program management, TB patients
Guidelines for Control of Tuberculosis in Prisons
Author(s): Tuberculosis Coalition for Technical Assistance, International Committee of the Red Cross
Year: 2009
Filed under: Drug-resistant TB, Guidance and Tools, Guidelines, mdr-tb, Prisons, TB control, Treatment, Universal access
Guidance for national tuberculosis programmes on the management of tuberculosis in children
Author(s): World Health Organization
Year: 2014
Filed under: Childhood TB, Children, Drug-resistant TB, Guidance, Guidance and Tools, NTP, TB and HIV, Universal access
Operational guidance on service delivery to TB patients (drug-susceptible and drug-resistant) during the COVID-19 pandemic
Author(s): Infectious Disease Society of Southern Africa
Year: 2020
Filed under: Coronavirus, COVID-19, DR-TB, Drug-resistant TB, Guidance, Guidance and Tools, Service delivery, TB care, TB patients
Community-based Care for Drug-resistant Tuberculosis: A Guide for Implementers
Author(s): TB Care II
Year: 2017
Filed under: Community, DR-TB, Drug-resistant TB, Guidance, Guidance and Tools, Program plannning, TB care, Technical Guidance
Management of drug-resistant tuberculosis
Author(s): The Lancet
Year: 2019
Filed under: DR-TB, Drug-resistant TB, mdr-tb, multidrug-resistant TB, Mycobacterium, TB patients, Treatment
Building a tuberculosis-free world: The Lancet Commission on tuberculosis
Author(s): The Lancet
Year: 2019
Filed under: Assessment, Drug-resistant TB, End TB, Journal Article, Mortality, Prevention, Research, Treament
Accelerating Action to End TB: Tuberculosis Report to Congress Fiscal Year 2018
Author(s): United States Agency for International Development
Year: 2020
Filed under: Accelerator, Drug-resistant TB, End TB, Governance, Journey to Self-Reliance, mdr-tb, Report, XDR-TB
